Chronic Pain in Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer

Recruiting

You are on the General Public view
  • Source

    -
    Public Title Chronic Pain in Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
    Acronym Sorry, not currently available
    Source of Record URL http://clinicaltrials.gov/show/NCT00971919
  • Trial

    -
    Health Condition(s) or Problem Breast Cancer; Pain; Perioperative/Postoperative Complications
    Lay Summary RATIONALE: Learning about chronic pain in women who have undergone surgery for breast cancer may help improve the quality of life for these patients and may help doctors plan the best treatment. PURPOSE: This clinical trial is studying chronic pain in women who have undergone surgery for stage I, stage II, or stage III breast cancer. (from ClinicalTrials.gov)
    Who can enter the trial DISEASE CHARACTERISTICS: - Histologically confirmed invasive breast cancer or carcinoma in situ of the breast by core biopsy or fine needle aspiration - Newly diagnosed disease - Stage I-III disease - Resectable disease - Being treated in the Aberdeen, Dundee, Perth, or Inverness Breast Unit - Planning to undergo primary surgical excision of the tumor (e.g., breast conservation surgery or mastectomy with or without axillary surgery [sentinel node biopsy, axillary sample, or axillary clearance]) - Planning to undergo standard adjuvant therapy after surgery, including radiotherapy, chemotherapy, and/or hormonal therapy, as per existing standard protocols - No detectable metastatic disease PATIENT CHARACTERISTICS: - Not pregnant - Speaks English - No history of mental illness PRIOR CONCURRENT THERAPY: - See Disease Characteristics
    Who cannot enter the trial DISEASE CHARACTERISTICS: - Histologically confirmed invasive breast cancer or carcinoma in situ of the breast by core biopsy or fine needle aspiration - Newly diagnosed disease - Stage I-III disease - Resectable disease - Being treated in the Aberdeen, Dundee, Perth, or Inverness Breast Unit - Planning to undergo primary surgical excision of the tumor (e.g., breast conservation surgery or mastectomy with or without axillary surgery [sentinel node biopsy, axillary sample, or axillary clearance]) - Planning to undergo standard adjuvant therapy after surgery, including radiotherapy, chemotherapy, and/or hormonal therapy, as per existing standard protocols - No detectable metastatic disease PATIENT CHARACTERISTICS: - Not pregnant - Speaks English - No history of mental illness PRIOR CONCURRENT THERAPY: - See Disease Characteristics
    What will happen Other; questionnaire administration; Procedure; assessment of therapy complications; Procedure; psychosocial assessment and care; Procedure; quality-of-life assessment
    Primary aim Chronic pain at or near the surgical site persisting beyond the expected healing time as measured at 4 and 9 months after surgery; Identification of which psychological and quality of life variables, after controlling for baseline demographic, surgical, and other factors, are predictive of chronic pain at 4 and 9 months after surgery; Association between chronic pain status at 4 and 9 months after surgery and differential changes in quality-of-life outcomes since baseline
    Secondary Aim Sorry, not currently available
    Participant Information Sheet Sorry, not currently available
    Website http://cancer.gov/clinicaltrials/EU-20926
    Recruitment Status Recruiting
    Nation Scotland
    Location Aberdeen
  • Contact

    -
    Contact for Public Queries Julie Bruce, MD, PhD Principal Investigator Aberdeen Royal Infirmary
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.